Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulating platelet function with selective thrombin inhibitors

M Verstraete1

  • 1Center for Molecular and Vascular Biology, University of Leuven, Belgium.

Haemostasis
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influencing factors in knee kinematics following posteriorly stabilized knee arthroplasty: a comprehensive analysis.

Acta orthopaedica Belgica·2025
Same author

Trends For Smaller Medical Journals.

Acta clinica Belgica·2016
Same author

Temperature dependence of the electronic structure of semiconductors and insulators.

The Journal of chemical physics·2015
Same author

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.

British journal of cancer·2015
Same author

[Update on the management of acute viral bronchiolitis: proposed guidelines of Grand Ouest University Hospitals].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2013
Same author

[Management of bronchiolitis in general practice and determinants of treatment being discordant with guidelines of the HAS].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2013
Same journal

Thrombosis and Haemostasis Issues in Cancer. International Conference. Bergamo, Italy, 2-4 November 2001. Lectures and abstracts.

Haemostasis·2002
Same journal

Biochemistry of cancer procoagulant.

Haemostasis·2002
Same journal

Management of thromboembolic disease in cancer patients.

Haemostasis·2002
Same journal

An overview of thromboprophylaxis in malignancy.

Haemostasis·2002
Same journal

Platelets cross-talk with tumor cells.

Haemostasis·2002
Same journal

Properties and function of heparanase in cancer metastasis and angiogenesis.

Haemostasis·2002
See all related articles

Selective thrombin inhibitors target thrombin-induced platelet aggregation, offering a focused approach to anticoagulation. These agents are currently under clinical investigation, with some demonstrating oral activity.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Hematology

Background:

  • Thrombin plays a critical role in blood coagulation.
  • Thrombin is a key agonist for platelet recruitment and aggregation.
  • Understanding thrombin's function is crucial for developing targeted therapies.

Purpose of the Study:

  • To review selective thrombin inhibitors.
  • To discuss their mechanism in impeding thrombin-induced platelet aggregation.
  • To highlight orally active agents in clinical development.

Main Methods:

  • Literature review of selective thrombin inhibitors.
  • Analysis of their effects on platelet aggregation.
  • Assessment of clinical investigation status.

Related Experiment Videos

Main Results:

  • Thrombin inhibitors selectively block thrombin-mediated platelet aggregation.
  • These inhibitors do not affect aggregation induced by other agonists.
  • Several selective thrombin inhibitors are in clinical trials, including orally active options.

Conclusions:

  • Selective thrombin inhibitors represent a targeted therapeutic strategy.
  • Their specificity for thrombin offers a distinct advantage over broader anticoagulants.
  • Ongoing clinical investigations suggest potential for new oral anticoagulation therapies.